Status:

COMPLETED

Safety Study of a Refrigerator-stable Formulation of VARIVAX®

Lead Sponsor:

Merck Sharp & Dohme LLC

Conditions:

Varicella

Measles

Eligibility:

All Genders

12-15 years

Phase:

PHASE4

Brief Summary

Primary objective: To describe the safety profile of a refrigerator-stable formulation of VARIVAX® as a first single dose injection in 12 to 15 month-old infants in the 42-day follow-up period post-v...

Eligibility Criteria

Inclusion

  • Healthy infants from 12 months of age to 15 months of age.
  • Consent form signed by both parents or by the legal representative(s), properly informed about the study,
  • Parent(s) able to understand the protocol requirements and to fill in the Diary Card.

Exclusion

  • Prior receipt of measles, mumps, rubella or varicella vaccine either alone or in combination vaccine,
  • Known or suspected clinical history of infection with measles, mumps, rubella, varicella or zoster,
  • Any known recent (≤30 days) exposure to measles, mumps or rubella,
  • Any known recent (≤30 days) exposure to varicella or zoster involving:
  • Any recent (≤3 days) history of febrile illness (rectal temperature ≥38.0°C),
  • Active untreated tuberculosis,
  • Any known blood dyscrasia, leukemia, lymphomas of any type, or other malignant neoplasms affecting the bone marrow or lymphatic systems,
  • Any immune impairment or humoral/cellular deficiency, neoplastic disease or depressed immunity,
  • Any previous (≤150 days) receipt of immune serum globulin or any blood-derived products or scheduled to be administered through visit 3,
  • Any recent receipt of an inactivated or a live vaccine (≤ 30 days) or scheduled vaccination through visit 3

Key Trial Info

Start Date :

December 1 2004

Trial Type :

INTERVENTIONAL

End Date :

September 1 2005

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT00432731

Start Date

December 1 2004

End Date

September 1 2005

Last Update

March 14 2017

Active Locations (25)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 7 (25 locations)

1

Amboise, France

2

Ancenis, France

3

Betton, France

4

Châteaubriant, France